These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8827561)

  • 1. Office probing for congenital nasolacrimal duct obstruction: a study of parental satisfaction.
    Goldblum TA; Summers CG; Egbert JE; Letson RD
    J Pediatr Ophthalmol Strabismus; 1996; 33(4):244-7. PubMed ID: 8827561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Office probing of congenital nasolacrimal duct obstruction.
    Stager D; Baker JD; Frey T; Weakley DR; Birch EE
    Ophthalmic Surg; 1992 Jul; 23(7):482-4. PubMed ID: 1407947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing for nasolacrimal duct obstruction with intravenous propofol sedation.
    Movaghar M; Kodsi S; Merola C; Doyle J
    J AAPOS; 2000 Jun; 4(3):179-82. PubMed ID: 10849396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
    Morrison DG; Binenbaum G; Chang MY; Heidary G; Trivedi RH; Galvin JA; Pineles SL
    Ophthalmology; 2021 Jun; 128(6):920-927. PubMed ID: 33358412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
    Cha DS; Lee H; Park MS; Lee JM; Baek SH
    Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Office probing for treatment of nasolacrimal duct obstruction in infants.
    Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
    J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
    Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
    J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Office-Based Nasolacrimal Duct Probing.
    Bach A; Vanner EA; Warman R
    J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):50-54. PubMed ID: 30371916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of probing for congenital nasolacrimal duct obstruction in older children.
    Honavar SG; Prakash VE; Rao GN
    Am J Ophthalmol; 2000 Jul; 130(1):42-8. PubMed ID: 11004258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric nasolacrimal duct obstruction.
    Schnall BM
    Curr Opin Ophthalmol; 2013 Sep; 24(5):421-4. PubMed ID: 23846190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry.
    Oke I; Elze T; Miller JW; Lorch AC; Hunter DG; Elliott AT;
    JAMA Ophthalmol; 2023 Apr; 141(4):342-348. PubMed ID: 36862386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal endoscopic silicone intubation for congenital obstruction of the nasolacrimal duct in children.
    Orhan M; Onerci M
    Int J Pediatr Otorhinolaryngol; 1997 Sep; 41(3):273-8. PubMed ID: 9350486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital nasolacrimal duct obstruction.
    Robb RM
    Ophthalmol Clin North Am; 2001 Sep; 14(3):443-6, viii. PubMed ID: 11705144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of therapy outcome in congenital nasolacrimal duct obstruction in own material].
    Lipiec E; Grałek M; Niwald A
    Klin Oczna; 2006; 108(4-6):174-7. PubMed ID: 17019988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early office-based vs late hospital-based nasolacrimal duct probing. A clinical decision analysis.
    Kassoff J; Meyer DR
    Arch Ophthalmol; 1995 Sep; 113(9):1168-71. PubMed ID: 7661751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.